11 apr: Europa/luk: Nådesløs afstraffelse af Nokia
12 apr: Selskabernes forventninger - torsdag den 12 april
11-04-2012 23:21:00

Quest Diagnostics Names Rusckowski As President, CEO

Relateret indhold

DOW JONES NEWSWIRES

Quest Diagnostics Inc. (DGX) named Royal Philips Electronics NV (PHG, PHIA.AE) executive Stephen Rusckowski as its new president and chief executive, ending a six-month search for a successor to current CEO Surya Mohapatra.

Rusckowski's appointment is effective May 1 and he will also join the company's board. Rusckowski has served as CEO of Philips Healthcare, Royal Philips' largest unit, since 2006.

The management change could mark a new course for the company. Some decisions Quest made under Mohapatra--such as the acquisition of diagnostics company AmeriPath Inc. and an expansion into India--have been criticized by analysts.

Quest, the largest diagnostic-testing company in the U.S. by revenue, had been hurt by a decline in doctor-office visits as consumers have reined in their health-care spending since the recession. Last year, the company unveiled a restructuring initiative to reduce its costs by $500 million over the next three years to help it meet profit targets. In October, the company initiated a search for a replacement for Mohapatra, who held the titles of chairman, president and CEO.

Quest also appointed lead director Daniel C. Stanzione as its new non-executive chairman.

"Steve Rusckowski is uniquely qualified to be chief executive officer of Quest Diagnostics," Stanzione said. "He has built an enviable track record in health care by successfully driving growth, both organically and through disciplined, effective acquisitions. His emphasis on operational excellence has enabled him to deliver consistently impressive results."

In January, Quest reported its fourth-quarter earnings rose 14% as the company saw higher testing revenue and improved margins.

Shares closed at $59.57 Wednesday and were unchanged after hours. The stock is up 2.6% since the start of the year.

-By Nathalie Tadena, Dow Jones Newswires; 212-416-3287; nathalie.tadena@dowjones.com

(END) Dow Jones Newswires

April 11, 2012 17:21 ET (21:21 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Norden/Carnegie: Sænker anbefaling til "sælg" fra "hold"

17-01-2017 15:20:25
Finanshuset Carnegie sænker anbefalingen af aktien i rederiet Norden til "sælg" fra "hold". Kursmålet er uændret 95 kr.Det fremgår af data fra Bloomberg News.No..

Shipping: Baltic Dry-indekset falder 0,3 pct. til 922 point

17-01-2017 14:05:16
Tørlastindekset Baltic Dry falder tirsdag med 0,3 pct. til 922 point. Det fremgår af data fra Bloomberg News.Baltic Dry-indekset udarbejdes af London-baserede B..

Aktier/åbning: Goldman giver Genmab gylden håndsrækning

17-01-2017 09:23:35
Et løftet kursmål fra den amerikanske investeringsbank Goldman Sachs har tirsdag sendt Genmab på vinderkurs i det toneangivende C20 Cap-indeks.Der er dog tale o..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/tendens: Novo og Genmab får løftet kursmål - ris til FLS og ALK
2
Aktier/åbning: Goldman giver Genmab gylden håndsrækning
3
Godt nyt til boligejerne: Uventet dyk i korte renter
4
Britisk leder melder om totalt exit fra EU og indre marked - NY2
5
General Motors efter kritik fra Trump: Investerer 1 mia. dollar i USA

Relaterede aktiekurser

Philips KON 28,24 -0,8% Fald i aktiekurs
Koninklijke Philips N.V... 30,26 -1,6% Fald i aktiekurs
Quest Diagnostics Incorp.. 92,26 -0,5% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
18. januar 2017 00:25:37
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170103.1 - EUROWEB5 - 2017-01-18 00:25:37 - 2017-01-18 00:25:37 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x